A new pill created to increase a woman's sex drive didn't have much impact on libido but did appear to slightly boost sexual satisfaction, according to two studies reviewed by the U.S. Food and Drug Administration.
The drug, called flibanserin, is related to the antidepressant family and affects serotonin and a number of other brain chemicals. Drug maker Boehringer Ingelheim is seeking FDA approval of the drug, the Associated Press reported.
On Friday, an FDA advisory panel of outside experts will meet to discuss the safety and effectiveness of flibanserin, including side effects such as depression, dizziness and fainting, and whether the drug should be approved by the FDA.
Many previous attempts to develop a so-called "female Viagra" were abandoned after showing little promise, the AP reported.